标题
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
作者
关键词
-
出版物
Journal of Evidence-Based Integrative Medicine
Volume 27, Issue -, Pages 2515690X2110688
出版商
SAGE Publications
发表日期
2022-01-12
DOI
10.1177/2515690x211068826
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Flavonolignans from silymarin do not intercalate into DNA : Rebuttal of data published in the paper J. Mol. Recognit . e2812 (2019)
- (2021) David Biedermann et al. JOURNAL OF MOLECULAR RECOGNITION
- Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin
- (2021) Václav Tvrdý et al. MEDICINAL RESEARCH REVIEWS
- Silymarin modulates catabolic cytokine expression through Sirt1 and SOX9 in human articular chondrocytes
- (2021) Wen-Tien Wu et al. Journal of Orthopaedic Surgery and Research
- Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
- (2021) Tomas Koltai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
- (2021) Marilyn Hagan et al. MOLECULES
- Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
- (2021) Sung-Hyun Kim et al. Oncology Letters
- Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes
- (2021) Zelma Faisal et al. BIOMEDICINE & PHARMACOTHERAPY
- Silymarin ameliorates the disordered glucose metabolism of mice with diet-induced obesity by activating the hepatic SIRT1 pathway
- (2021) Bin Feng et al. CELLULAR SIGNALLING
- Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells
- (2021) Alexis Rugamba et al. Cells
- Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
- (2021) Maryam Fallah et al. BIOMEDICINE & PHARMACOTHERAPY
- Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4
- (2020) Sedat Kacar et al. MEDICAL ONCOLOGY
- Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway
- (2020) Nuriye Ezgi Bektur Aykanat et al. Pharmacological Reports
- Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system
- (2020) Chao Yang et al. ANTI-CANCER DRUGS
- Silymarin and Derivatives: From Biosynthesis to Health Benefits
- (2020) Dominique Delmas MOLECULES
- Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model
- (2020) Bruna Girardi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preventive effect of silymarin-loaded chitosan nanoparticles against global cerebral ischemia/reperfusion injury in rats
- (2020) Akbar Hajizadeh Moghaddam et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double‐blind placebo‐controlled trial
- (2020) Zohreh Saberi et al. PHYTOTHERAPY RESEARCH
- Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
- (2020) Leïla Sarah Sellam et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation
- (2020) Uma Sankar Gorla et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats
- (2020) Ahmet Yardım et al. GENE
- Improving Silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease
- (2020) Thu-Ha Thi Nguyen et al. JOURNAL OF CONTROLLED RELEASE
- Dibenzazepine combats acute liver injury in rats via amendments of Notch signaling and activation of autophagy
- (2020) Lamiaa A. Ahmed et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
- (2020) Rasool Haddadi et al. PHYTOMEDICINE
- Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells
- (2020) Jagan Mohan Kaipa et al. PeerJ
- Skin Protective Activity of Silymarin and its Flavonolignans
- (2019) Jitka Vostálová et al. MOLECULES
- Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro
- (2019) Maryam Shariati et al. INFLAMMATION
- Silibinin-induced apoptosis of breast cancer cells involves mitochondrial impairment
- (2019) Lingling Si et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway
- (2019) Manish Adhikari et al. Cell Communication and Signaling
- Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin
- (2019) Vieri Piazzini et al. MOLECULES
- Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers
- (2019) Yizuo Song et al. Molecular Therapy-Oncolytics
- The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela
- (2019) Rosa Cardone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art
- (2019) Alfonso Di Costanzo et al. MOLECULES
- Clathrin switches Transforming Growth Factor-β role to pro-tumorigenic in liver cancer
- (2019) Daniel Caballero-Díaz et al. JOURNAL OF HEPATOLOGY
- Intercalation of a flavonoid, silibinin into DNA base pairs: Experimental and theoretical approach
- (2019) Suma K. Pawar et al. JOURNAL OF MOLECULAR RECOGNITION
- Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling
- (2019) Jie Li et al. LIFE SCIENCES
- Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives
- (2019) Jitka Viktorová et al. Antioxidants
- Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression
- (2018) Salma M. Eraky et al. BIOMEDICINE & PHARMACOTHERAPY
- Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice
- (2018) Shu Yun Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT
- (2018) Jie Mao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Silibinin is a direct inhibitor of STAT3
- (2018) Sara Verdura et al. FOOD AND CHEMICAL TOXICOLOGY
- In vitro and in vivo anti-cancer activity of silymarin on oral cancer
- (2018) Dong-Hoon Won et al. TUMOR BIOLOGY
- Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress
- (2018) Fernanda Caetano Camini et al. ANTIVIRAL RESEARCH
- Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review
- (2018) Sahar Fanoudi et al. DRUG AND CHEMICAL TOXICOLOGY
- Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-ß1b-Treated MS Patients
- (2018) Fereshteh Navabi et al. INFLAMMATION
- Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation
- (2018) Zhengzheng Shi et al. LIFE SCIENCES
- Design and discovery of silybin analogues as antiproliferative compounds using a ring disjunctive – Based, natural product lead optimization approach
- (2017) Elangovan Manivannan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-β1/Smad 2/3 signaling
- (2017) Je-Won Ko et al. FOOD AND CHEMICAL TOXICOLOGY
- Silymarin protects against renal injury through normalization of lipid metabolism and mitochondrial biogenesis in high fat-fed mice
- (2017) Bin Feng et al. FREE RADICAL BIOLOGY AND MEDICINE
- Silymarin impacts on immune system as an immunomodulator: One key for many locks
- (2017) Nafiseh Esmaeil et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-inflammatory Effect of Silymarin on Ovarian Immunohistochemical Localization of TNF- Associated with Systemic Inflammation in Polycystic Ovarian Syndrome
- (2017) Parvin Kayedpoor et al. INTERNATIONAL JOURNAL OF MORPHOLOGY
- Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner
- (2017) Yi Sun et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Chronic Silymarin, Quercetin and Naringenin Treatments Increase Monoamines Synthesis and Hippocampal Sirt1 Levels Improving Cognition in Aged Rats
- (2017) F. Sarubbo et al. Journal of Neuroimmune Pharmacology
- Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
- (2017) Alessandro Federico et al. MOLECULES
- Effects of Silymarin on Diabetes Mellitus Complications: A Review
- (2017) Aline Maria Stolf et al. PHYTOTHERAPY RESEARCH
- Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks
- (2017) Evgeny Gladilin PLoS One
- Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade
- (2017) Eun-Sun Choi et al. CELLULAR ONCOLOGY
- Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
- (2017) Valentina Belli et al. Oncotarget
- Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways
- (2017) Mitsuho Imai-Sumida et al. Oncotarget
- HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies
- (2017) Haneen Amawi et al. Frontiers in Pharmacology
- Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner
- (2017) Yi-Hao Chen et al. PLoS One
- Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells
- (2016) Hyun Ji Eo et al. Biomolecules & Therapeutics
- STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
- (2016) Elisabet Cuyàs et al. CELL CYCLE
- A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan
- (2016) Minh-Hiep Nguyen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Modulation of WNT/β-catenin pathway in melanoma by biologically active components derived from plants
- (2016) Anna Gajos-Michniewicz et al. FITOTERAPIA
- Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status
- (2016) Daiane Teixeira de Oliveira et al. JOURNAL OF BIOSCIENCES
- Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H 2 S
- (2016) Nahla N. Younis et al. JOURNAL OF SURGICAL RESEARCH
- Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway
- (2016) NAN FENG et al. Molecular Medicine Reports
- Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice
- (2016) Ge Jin et al. NEUROSCIENCE LETTERS
- Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
- (2016) Ommoleila Molavi et al. PHARMACEUTICAL BIOLOGY
- Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression
- (2016) Sangmin Kim et al. TUMOR BIOLOGY
- Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury
- (2016) Yanwu Jin et al. Experimental and Therapeutic Medicine
- Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
- (2016) Joaquim Bosch-Barrera et al. Oncotarget
- Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2016) Luminita Voroneanu et al. Journal of Diabetes Research
- Protective Role of Sylimarin on Methotrexate induced Hepato-nephrotoxicity in Children with Acute Lymphoblastic Leukemia
- (2016) Adel Abd Elhaleim Hagag Mediterranean Journal of Hematology and Infectious Diseases
- Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468
- (2015) Pegah Abdollahi et al. ANTI-CANCER DRUGS
- Silymarin and hepatocellular carcinoma
- (2015) Jeanetta K. Mastron et al. ANTI-CANCER DRUGS
- Silibilin-Induces Apoptosis in Breast Cancer Cells by Modulating p53, p21, Bak and Bcl-xl Pathways
- (2015) Mohammad Bagher Pirouzpanah et al. Asian Pacific Journal of Cancer Prevention
- Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells
- (2015) Wan Feng et al. BIOMEDICINE & PHARMACOTHERAPY
- A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer
- (2015) M. Lazzeroni et al. Cancer Prevention Research
- Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression
- (2015) Mingjie Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells
- (2015) Hyun Ji Eo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats
- (2015) Simona Clichici et al. JOURNAL OF MEDICINAL FOOD
- ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells
- (2015) Nan Zheng et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells
- (2015) KAI JIANG et al. ONCOLOGY REPORTS
- The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
- (2015) Debashish Sahay et al. Oncotarget
- Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
- (2015) Surendra K. Shukla et al. Oncotarget
- Antiviral activity of silymarin against chikungunya virus
- (2015) Rafidah Lani et al. Scientific Reports
- In VitroAntimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
- (2015) Dayanne Rakelly de Oliveira et al. Biomed Research International
- Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells
- (2014) Li Fan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of SIRT1 Signaling Sensitizes the Antitumor Activity of Silybin against Human Lung Adenocarcinoma Cells In Vitro and In Vivo
- (2014) Z. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2
- (2014) Harold J. Ting et al. MOLECULAR CARCINOGENESIS
- Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis
- (2014) Mudit Vaid et al. MOLECULAR CARCINOGENESIS
- Chemistry of silybin
- (2014) D. Biedermann et al. NATURAL PRODUCT REPORTS
- Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
- (2014) Parvin Forghani et al. Cancer Medicine
- Introduction of a mathematical model for optimizing the drug release in the patient’s body
- (2014) Mohammad Reza Nabatchian et al. DARU-Journal of Pharmaceutical Sciences
- Structure–Activity Relationship for (+)-Taxifolin Isolated from Silymarin as an Inhibitor of Amyloid β Aggregation
- (2013) Mizuho SATO et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Emerging phytochemicals for prevention of melanoma invasion
- (2013) Virginia Jones et al. CANCER LETTERS
- Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
- (2013) M.-H. Lee et al. Cancer Prevention Research
- The Notch signaling pathway as a mediator of tumor survival
- (2013) K. M. Capaccione et al. CARCINOGENESIS
- Stem cell-like ALDHbrightcellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin
- (2013) BRUNA COROMINAS-FAJA et al. CELL CYCLE
- Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness
- (2013) Kaijie Wu et al. CELLULAR SIGNALLING
- Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action
- (2013) Anupom Borah et al. CNS Neuroscience & Therapeutics
- Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells
- (2013) Sílvia Cufí et al. FOOD AND CHEMICAL TOXICOLOGY
- Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma
- (2013) Marco Moroni et al. Future Oncology
- Silibinin Inhibits Tumor Growth through Downregulation of Extracellular Signal-Regulated Kinase and Akt in Vitro and in Vivo in Human Ovarian Cancer Cells
- (2013) Hyun Jin Cho et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Increase of Phosphatase and Tensin Homolog by Silymarin to Inhibit Human Pharynx Squamous Cancer
- (2013) Chin-Hui Su et al. JOURNAL OF MEDICINAL FOOD
- The Effect of Silymarin on Mesenteric Ischemia-Reperfusion Injury
- (2013) M. Demir et al. MEDICAL PRINCIPLES AND PRACTICE
- Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells
- (2013) Charlotte M Smith et al. Molecular Cancer
- Silymarin suppresses the PGE2-induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways
- (2013) Seon Min Woo et al. MOLECULAR CARCINOGENESIS
- Bioavailability of silymarin flavonolignans: drug formulations and biotransformation
- (2013) Eleni Theodosiou et al. PHYTOCHEMISTRY REVIEWS
- Use of selenium–silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men
- (2013) Jitka Vostalova et al. PHYTOMEDICINE
- Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells
- (2013) Song Zhang et al. PLoS One
- Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma
- (2013) Jun S. Wei et al. PLoS One
- TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression
- (2013) Yixuan Gong et al. PLoS One
- Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats
- (2013) Reem T. Atawia et al. TOXICOLOGY LETTERS
- Endocytosis and Cancer
- (2013) I. Mellman et al. Cold Spring Harbor Perspectives in Biology
- Null anticarcinogenic effect of silymarin on diethylnitrosamine-induced hepatocarcinogenesis in rats
- (2013) RYU IMAMOTO et al. Experimental and Therapeutic Medicine
- Dual Effects of Silymarin on Nasopharyngeal Carcinoma Cells (NPC-TW01)
- (2013) Chin-Hui Su et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Mohammad Kazem Fallahzadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Silymarin for HCV infection
- (2012) Stephen J Polyak et al. ANTIVIRAL THERAPY
- The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells
- (2012) Henriette Kauntz et al. APOPTOSIS
- Silymarin regulates HIF-1α and iNOS expression in the brain and gills of hypoxic-reoxygenated rainbow trout Oncorhynchus mykiss
- (2012) H Malekinejad et al. Aquatic Biology
- Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice
- (2012) Elizabeth Brandon-Warner et al. CANCER LETTERS
- In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
- (2012) Dhanya Nambiar et al. CANCER LETTERS
- Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
- (2012) Wenyan Lu et al. CELLULAR SIGNALLING
- A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis
- (2012) Mansoor Rastegarpanah et al. Chinese Journal of Integrative Medicine
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells
- (2012) Samiha Mateen et al. Epigenetics
- Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
- (2012) Stephen J. Polyak et al. HEPATOLOGY
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions
- (2012) Z. J. Rutnam et al. JOURNAL OF CELL SCIENCE
- Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes
- (2012) Ömer Koz et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Therapeutic Efficacy of Silibinin on Human Neuroblastoma Cells: Akt and NF-κB Expressions May Play an Important Role in Silibinin-Induced Response
- (2012) Meysam Yousefi et al. NEUROCHEMICAL RESEARCH
- Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis
- (2012) Naglaa M El-Lakkany et al. Parasites & Vectors
- Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells
- (2012) Kohei Kato et al. TUMOR BIOLOGY
- Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells
- (2011) Henriette Kauntz et al. APOPTOSIS
- Molecular Mechanism of Silymarin-Induced Apoptosis in a Highly Metastatic Lung Cancer Cell Line Anip973
- (2011) Wenhai Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells
- (2011) Y. Ward et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds
- (2011) Murat Şentürk et al. Chemical Biology & Drug Design
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Silibinin Causes Apoptosis and Cell Cycle Arrest in Some Human Pancreatic Cancer Cells
- (2011) Yakun Ge et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis
- (2011) I-Shu Chen et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI
- (2011) Mohadeseh Dastpeyman et al. MEDICAL ONCOLOGY
- Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
- (2011) J. Zeng et al. MOLECULAR CANCER THERAPEUTICS
- Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells
- (2011) Alpna Tyagi et al. MOLECULAR CARCINOGENESIS
- Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel
- (2011) Horng-Rong Chang et al. MOLECULAR CARCINOGENESIS
- Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF-κB signaling
- (2011) Komal Raina et al. MOLECULAR CARCINOGENESIS
- Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog
- (2011) Hann-Chin Yu et al. PHYTOTHERAPY RESEARCH
- Silymarin Protects Epidermal Keratinocytes from Ultraviolet Radiation-Induced Apoptosis and DNA Damage by Nucleotide Excision Repair Mechanism
- (2011) Santosh K. Katiyar et al. PLoS One
- Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells
- (2011) Mudit Vaid et al. PLoS One
- Silymarin Attenuated the Amyloid β Plaque Burden and Improved Behavioral Abnormalities in an Alzheimer’s Disease Mouse Model
- (2010) Nakaba MURATA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
- (2010) Gagan Deep et al. CANCER AND METASTASIS REVIEWS
- Chemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
- (2010) S. Rajamanickam et al. CANCER RESEARCH
- Multiple effects of silymarin on the hepatitis C virus lifecycle
- (2010) Jessica Wagoner et al. HEPATOLOGY
- Effect of sowing date and rate on the yield and flavonolignan content of the fruits of milk thistle (Silybum marianum L. Gaertn.) grown on light soil in a moderate climate
- (2010) Jadwiga Andrzejewska et al. INDUSTRIAL CROPS AND PRODUCTS
- Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures
- (2010) A. Y. AU et al. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
- Combined Treatment with Silibinin and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Overcomes Drug Resistance Caused by T790M Mutation
- (2010) J. K. Rho et al. MOLECULAR CANCER THERAPEUTICS
- Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling
- (2010) Gagan Deep et al. MOLECULAR CARCINOGENESIS
- Preventive effect of silymarin in cerebral ischemia–reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation
- (2010) Yu-Chang Hou et al. PHYTOMEDICINE
- Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus
- (2010) C. Soto et al. PHYTOMEDICINE
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer
- (2010) Thomas W. Flaig et al. PROSTATE
- Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
- (2009) Kai-jie Wu et al. ACTA PHARMACOLOGICA SINICA
- Silibinin inhibits expression of HIF-1α through suppression of protein translation in prostate cancer cells
- (2009) Hui-Jung Jung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor- B and Signal Transducers and Activators of Transcription 3
- (2009) A. Tyagi et al. Cancer Prevention Research
- Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells
- (2009) G. Ramakrishnan et al. CELL PROLIFERATION
- Micronization of silybin by the emulsion solvent diffusion method
- (2009) Zhi-Bing Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators
- (2009) Samiha Mateen et al. MOLECULAR CARCINOGENESIS
- Silibinin Suppresses Spontaneous Tumorigenesis in APC min/+ Mouse Model by Modulating Beta-Catenin Pathway
- (2009) Subapriya Rajamanickam et al. PHARMACEUTICAL RESEARCH
- Silymarin BIO-C®, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats
- (2009) Raffaele Capasso et al. PHYTOMEDICINE
- Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells
- (2009) Sangmin Kim et al. PHYTOMEDICINE
- Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats
- (2009) Nagla A. El-Shitany et al. PHYTOMEDICINE
- Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice
- (2009) Wei Cui et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR–ERK activation in renal cell carcinoma
- (2008) Lei Li et al. CANCER LETTERS
- Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line
- (2008) M MOKHTARI et al. CELL BIOLOGY INTERNATIONAL
- Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice
- (2008) R. P. Singh et al. CLINICAL CANCER RESEARCH
- Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation
- (2008) Majid Momeny et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells
- (2008) Gagan Deep et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
- (2008) Zheng-Sheng Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Antioxidant and protective effects of silymarin on ischemia and reperfusion injury in the kidney tissues of rats
- (2008) Faruk Turgut et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis
- (2008) Gopalakrishnan Ramakrishnan et al. INVESTIGATIONAL NEW DRUGS
- Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma
- (2008) Gopalakrishnan Ramakrishnan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney
- (2008) Hakan Senturk et al. WORLD JOURNAL OF UROLOGY
- Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation
- (2008) Enzo Berardesca et al. Journal of Cosmetic Dermatology
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started